Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Pediatr Res. 2011 Dec;70(6):578–583. doi: 10.1203/PDR.0b013e318232a984

Fig. 6. Farnesol decreases bioluminescence in S. epidermidis catheter infection in vivo.

Fig. 6

A bioluminescent strain of S. epidermidis 1457 Xen 43 was used in the subcutaneous catheter infection model in mice and bioluminescence followed serially for 5 days (A). Mice were treated with farnesol at 100 µg/g/day or DMSO (control) from day 2 of infection for 4 days. Bioluminescence was quantified and expressed as average radiance in photons/sec/cm2 (B). Farnesol treatment (□) decreased bioluminescence significantly (*, ** and #, p < 0.05) on days 3, 4 and 5 compared to DMSO control (■).